ISIN
NL00150002Q7
Ticker
VVY
Sector
Sub-Industry
Country
Netherlands
Year Founded
1997
We are focused on developing innovative small molecule-based medicines. Driven by our passion for ground-breaking science and innovation, we strive to change the lives of patients in need suffering from severe diseases. We build on our in-depth expertise in understanding post-translational modifications to develop medicines that modulate the activity and stability of proteins which are altered in disease settings
Europe
Date | Trading entity / Person | Association | Trade type | Volume |
---|---|---|---|---|
01.04.2022 | E. Platzer | Executive member | Buy | EUR 1,299,994.50 |
01.04.2022 | U. Dauer | Executive member | Buy | EUR 49,990.50 |
02.12.2020 | D.J. von der Osten | Executive member | Buy | EUR 112,400.00 |
30.11.2020 | M. Schaeffer | Executive member | Other | EUR 0.00 |
Position Holder | Short Interest in Percent | Date |
---|---|---|
Millennium International Management LP | 0.61% | 08.04.24 |
Janus Henderson Investors UK Limited | 0.59% | 22.06.23 |
Citadel Securities (Europe) Limited | 0.51% | 12.07.24 |
Adage Capital Management L.P. | 0.54% | 09.01.24 |
GSA Capital Partners LLP | 0.53% | 14.03.24 |
Voleon Capital Management LP | 0.57% | 28.06.24 |
Total | 3.35% |
NL00150002Q7
3912004AMB0KGZXZYJ15
Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.